SCHEMBL6067975

SCHEMBL6067975

Cc1ccc(-c2ccc(O)cc2O)cc1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.61
ACHE P22303 1/20 0.52
ESR2 Q92731 6/20 0.50
ESR1 P03372 6/20 0.50
CA12 O43570 1/20 0.49
CA9 Q16790 1/20 0.49
MIF P14174 1/20 0.49
MAOA P21397 1/20 0.49
MAOB P27338 1/20 0.49
HSD17B1 P14061 1/20 0.47
BACE1 P56817 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
COMT P21964 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10068940 0.86 TRPA1 (0.56) ALOX5ACHECA12CA9BACE1
SCHEMBL278379 0.85 ALOX5 (0.73) ALOX5ESR2ESR1HSD17B1HSD17B10
SCHEMBL29615176 0.84 BACE1 (0.56) ALOX5ACHEESR2ESR1CA12
SCHEMBL1163817 0.84 BACE1 (0.56) ALOX5ACHEESR2ESR1CA12
SCHEMBL1006436 0.84 MCL1 (0.52) ALOX5ACHECA12CA9BACE1
SCHEMBL3811869 0.83 ALOX5 (0.70) ALOX5ESR2ESR1HSD17B1HSD17B10
SCHEMBL27619639 0.82 ALOX5 (0.56) ALOX5ESR2ESR1
SCHEMBL20690490 0.82 ALOX5 (0.56) ALOX5ACHEESR2ESR1HSD17B1
SCHEMBL26437159 0.81 TRPA1 (0.56) ALOX5ACHEESR2ESR1HSD17B10
SCHEMBL19334620 0.81 ACHE (0.65) ACHEESR2ESR1CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7125428-B2 1,3-Dihydroxybenzene derivatives and colorants containing said compounds WELLA AG (DE) 2006-10-24 US disclosed
EP-1392673-A2 1,3-DIHYDROXYBENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS Wella Aktiengesellschaft (DE) 2004-03-03 EP disclosed
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2004-01-29 US disclosed
WO-2002096901-A2 1,3-DIHYDROXYBENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2002-12-05 WO disclosed
EP-0534204-B1 Base developable negative photoresist and use thereof IBM (US) 1997-06-04 EP disclosed
EP-0534204-A1 Base developable negative photoresist and use thereof International Business Machines Corporation (US) 1993-03-31 EP disclosed
US-5087548-A POSITIVE TYPE RADIATION-SENSITIVE RESIN COMPOSITION JAPAN SYNTHETIC RUBBER CO., INC. (JP) 1992-02-11 US disclosed
EP-0009190-B1 CURABLE COMPOSITION USEFUL FOR SCREEN-PRINTING, A CURED COATING COMPRISING SAID COMPOSITION AND PROCESS FOR SOLDERING PRINTED CIRCUIT BOARDS USING SAID COMPOSITION International Business Machines Corporation (US) 1982-04-28 EP disclosed
EP-0009190-A1 Curable composition useful for screen-printing, a cured coating comprising said composition and process for soldering printed circuit boards using said composition International Business Machines Corporation (US) 1980-04-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds KRT18, DSP, COL1A1 ALOX5 3355/4885ACHE 1194/4885ESR2 1641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.